X-j Jiang-Xijuan
Tianjin, 301617, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
PANoptosis in infectious Diseases: Mechanisms, therapeutic potential, and future directions.
Journal: Biochemical and biophysical research communications
Published: June 03, 2025
Mitochondrial DNA in atherosclerosis: Mechanisms, biomarker potential, and therapeutic perspectives.
Mitochondrial DNA in atherosclerosis: Mechanisms, biomarker potential, and therapeutic perspectives.
Journal: International immunopharmacology
Published: January 15, 2025
Copper homeostasis and Cuprotosis: Exploring novel therapeutic strategies for connective tissue diseases.
Journal: International immunopharmacology
Published: October 03, 2024
Ferroptosis in neurodegenerative diseases: inhibitors as promising candidate mitigators.
Journal: European review for medical and pharmacological sciences
Published: January 17, 2023
Killing two birds with one stone: miR-126 involvement in both cancer and atherosclerosis.
Journal: European review for medical and pharmacological sciences
Published: September 16, 2022
Shengmai Yin formula exerts cardioprotective effects on rats with chronic heart failure via regulating Linoleic Acid metabolism.
Journal: Prostaglandins & other lipid mediators
Published: September 18, 2021
The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.
Journal: Scientific reports
Published: March 13, 2021
New Classification of Macrophages in Plaques: a Revolution.
Journal: Current atherosclerosis reports
Published: June 20, 2020
Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review.
Journal: Inflammation
Published: October 25, 2019
Gasdermin family: a promising therapeutic target for cancers and inflammation-driven diseases.
Journal: Journal of cell communication and signaling
Published: August 13, 2019
Ethanol extracts of Danlou tablet attenuate atherosclerosis via inhibiting inflammation and promoting lipid effluent.
Journal: Pharmacological research
Published: February 14, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026